AI Drug Development Companies

5/5 - (1 vote)

Some other AI Drug Development Companies

S. no. Company name Website Small description
1 Atomwise atomwise.com Transforming virtual screening through deep learning
2 Molecule AI moleculeai.com AI-driven platform for correct drug design.
3 TwoXAR twoxar.com Rapid assessment and listing of drug candidates.
4 Recce Pharmaceuticals recce.com Incorporation of AI in emerging innovative antibiotics.
5 Biosymetrics biosymetrics.com United data analytics platform for all-inclusive insights.
6 Cyclica cyclicarx.com Survey of polypharmacology and network pharmacology.
7 Ardigen ardigen.com AI progressions in immunotherapy research.
8 Healx healx.io AI-driven rare disease drug discovery lecturing unmet needs.

 

Conclusion

The development of AI tools consistently keeps an aim for decreasing difficulties that drug Development companies face. The existing healthcare sector is facing numerous complicated challenges like enhanced cost of drugs and other therapies, and society requires specified substantial changes in this area.

With AI, it’s possible to manufacture drugs, customize medicines with desired dosage, release parameters and other such needed aspects.

AI-based technologies not only help in speeding up the time required for product quality and overall safety of the manufacturing process and offer good utilization of available resources in addition to cost-efficient therapies by enhancing the vitality of automation.

Also read:

FAQs

Does AI have a role in drug development?

Yes, AI can support several stages of drug discovery in many ways which involve disease recognition, acquisition of target, computational screening, prediction of drug toxicity, gene editing etc.

What changes AI can bring in drug development?

It helps in speeding up the testing process and reduces the elongated period in which the biological target responsible for any disease is recognized.

What are the difficulties of AI in drug development?

There is a lack of transparency, lack of data availability and also biases in data.

Leave a Comment